These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35145480)

  • 1. Features of Lymph Node Metastasis and Structural Recurrence in Papillary Thyroid Carcinoma Located in the Upper Portion of the Thyroid: A Retrospective Cohort Study.
    Heng Y; Feng S; Yang Z; Cai W; Qiu W; Tao L
    Front Endocrinol (Lausanne); 2021; 12():793997. PubMed ID: 35145480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of thyroid carcinoma invasion of recurrent laryngeal nerve on cervical lymph node metastasis.
    Zhu F; Shen Y; Zhu L; Chen L; Li F; Xie X; Wu Y
    Endocrine; 2024 Nov; 86(2):654-663. PubMed ID: 38767775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.
    Hu D; Lin H; Zeng X; Wang T; Deng J; Su X
    World J Surg; 2020 May; 44(5):1498-1505. PubMed ID: 31863139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1-2 Central Lymph Node Metastases.
    Wang Y; Deng C; Shu X; Yu P; Wang H; Su X; Tan J
    Front Endocrinol (Lausanne); 2021; 12():716728. PubMed ID: 34721289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Specific Predicting Model for Screening Skip Metastasis From Patients With Negative Central Lymph Nodes Metastasis in Papillary Thyroid Cancer.
    Yang Z; Heng Y; Zhao Q; Cao Z; Tao L; Qiu W; Cai W
    Front Endocrinol (Lausanne); 2021; 12():743900. PubMed ID: 34659126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with preferential lateral lymph node metastasis in papillary thyroid carcinoma.
    Shao L; Wang Z; Dong W; Sun W; Zhang H
    Cancer Med; 2023 Nov; 12(22):20670-20676. PubMed ID: 37905599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis.
    Dou Y; Hu D; Chen Y; Xiong W; Xiao Q; Su X
    World J Surg Oncol; 2020 Jul; 18(1):188. PubMed ID: 32723382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy.
    Gong Y; Yang J; Yan S; Su A; Liu F; Gong R; Zhu J; Li Z
    Medicine (Baltimore); 2018 Sep; 97(36):e12263. PubMed ID: 30200164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma.
    Kim WW; Yang SI; Kim JH; Choi YS; Park YH; Kwon SK
    World J Surg Oncol; 2012 Oct; 10():226. PubMed ID: 23110552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
    Zhao H; Huang T; Li H
    Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary thyroid carcinoma located in the isthmus or upper third is associated with Delphian lymph node metastasis.
    Chai YJ; Kim SJ; Choi JY; Koo do H; Lee KE; Youn YK
    World J Surg; 2014 Jun; 38(6):1306-11. PubMed ID: 24366273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factors analyses for lateral neck lymph node metastasis in papillary thyroid carcinoma].
    Qi ZJ; Liu LF; Cheng L; Han X; Wang T; Li F; Lu C; Zhang AB
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):603-606. PubMed ID: 31327195
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):625-632. PubMed ID: 30841713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma.
    Feng JW; Qin AC; Ye J; Pan H; Jiang Y; Qu Z
    Endocr Pathol; 2020 Mar; 31(1):67-76. PubMed ID: 31828583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
    Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
    BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of sentinel Lymph node biopsy in the lateral neck in papillary thyroid carcinoma.
    Yan XQ; Ma ZS; Zhang ZZ; Xu D; Cai YJ; Wu ZG; Zheng ZQ; Xie BJ; Cao FL
    Front Endocrinol (Lausanne); 2022; 13():937870. PubMed ID: 35957824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.